Journal of Investigative Dermatology, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Journal of Investigative Dermatology, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
European Journal of Pharmaceutics and Biopharmaceutics, Journal Year: 2025, Volume and Issue: 210, P. 114692 - 114692
Published: March 11, 2025
Language: Английский
Citations
0Gels, Journal Year: 2025, Volume and Issue: 11(4), P. 228 - 228
Published: March 22, 2025
Psoriasis is a chronic skin disease caused by the interaction of multiple factors that leads to abnormal growth stratum corneum cells and has been called an immortal cancer. Docetaxel trialed for treatment psoriasis due its superior ability induce apoptosis, but insolubility low bioavailability have hampered development. Here, docetaxel (DTX)-loaded liposomes-in-gel (DTX-LP-G) as transdermal delivery was investigated via modulating IL6-HIF-1α-VEGF axis. The results demonstrated DTX-LP-G cumulatively released much higher amount drug into than from DTX-loaded liposomes (DTX-LPs) gel (DTX-G). also most efficient in scavenging hydrogen peroxide free radicals vitro. In mouse model psoriasis, acted preliminary therapeutic agent terms apparent evaluation, splenomegaly, suppression MDA content tissue, down-regulated expression IL6, HIF-1α, VEGF control proliferation vessels, except less pronounced effect on corneum. addition, enrichment analysis can speculate DTX treated resisting production keratin-forming cells.
Language: Английский
Citations
0Archives of Dermatological Research, Journal Year: 2025, Volume and Issue: 317(1)
Published: April 11, 2025
Language: Английский
Citations
0Deleted Journal, Journal Year: 2025, Volume and Issue: 2(1)
Published: April 14, 2025
Language: Английский
Citations
0Journal of Investigative Dermatology, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0